For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 ...
Hosted on MSN
Could removing lymph nodes actually WEAKEN the immune system's power to attack cancer cells?
For years, it has been a mainstay of treatment to stop the spread of many cancers. But is the removal of lymph nodes – tiny, bean-shaped nodules that filter waste and bacteria – really the best way to ...
Removing lymph nodes during cancer surgery has saved countless lives in many tumor types. Yet recent research is challenging parts of this long-standing practice. Imagine your body's immune defenses ...
Dr. Ko Un “Clara” Park and Dr. Mylin Torres present the latest evidence-based changes to the SLNB in early-stage breast cancer guideline. They discuss the practice-changing trials that led to the ...
Gastric cancer (GC) remains an oncological challenge, with lymph node involvement being a major prognostic factor. Sentinel lymph node (SLN) mapping may improve staging and reduce morbidity. This ...
For clinically node-negative (cN0) breast cancer patients with sonographically suspicious lymph nodes (iN+) but negative fine-needle aspiration cytology (N0(f)), sentinel lymph node biopsy (SLNB) ...
Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...
Sentinel lymph node (SLN) biopsy for early cervical cancer achieved non-inferiority versus pelvic lymphadenectomy, according to results of a large randomized study from China. Patients assigned to SLN ...
TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting II. This abstract does not ...
Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results